Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 63.94B | 51.50B | 53.40B | 47.44B | 40.14B |
Gross Profit | 9.30B | 1.56B | 5.76B | 5.87B | 3.65B |
EBITDA | 3.73B | -5.48B | 4.51B | 4.59B | 2.98B |
Net Income | -769.00M | -11.82B | 557.00M | 904.00M | 61.00M |
Balance Sheet | |||||
Total Assets | 60.17B | 60.45B | 63.73B | 57.93B | 53.38B |
Cash, Cash Equivalents and Short-Term Investments | 9.20B | 7.42B | 7.71B | 7.51B | 7.57B |
Total Debt | 15.58B | 14.79B | 11.03B | 7.22B | 4.34B |
Total Liabilities | 33.58B | 31.10B | 25.70B | 20.75B | 17.06B |
Stockholders Equity | 26.59B | 29.35B | 38.03B | 37.18B | 36.32B |
Cash Flow | |||||
Free Cash Flow | -2.44B | -3.95B | -2.32B | -2.07B | -2.19B |
Operating Cash Flow | 654.00M | 678.00M | 1.69B | 3.17B | 3.01B |
Investing Cash Flow | 1.00B | -4.32B | -4.95B | -4.82B | -4.36B |
Financing Cash Flow | -284.00M | 2.88B | 2.78B | 1.15B | 250.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥11.00B | 4.24 | 2.49% | -4.83% | 5.31% | ||
77 Outperform | ¥8.89B | 7.26 | 3.41% | 7.41% | 7.38% | ||
74 Outperform | ¥11.98B | 4.77 | 4.64% | 0.85% | 94.79% | ||
70 Outperform | ¥10.34B | 6.00 | 4.26% | 0.93% | -7.85% | ||
68 Neutral | ¥15.67B | 5.41 | 3.25% | 20.25% | ― | ||
67 Neutral | ¥17.80B | 282.43 | 0.37% | 2.22% | -90.98% | ||
56 Neutral | HK$25.46B | 5.05 | -2.69% | 5.69% | -0.43% | -53.15% |